Chemistry / CMC
Ian Davies, PhD
-
20+ years at Merck
-
>200 drug candidates
-
Director, Princeton Catalysis Institute
Toxicology
Lee Silverman, DVM, PhD
-
20+ years industry experience
-
Toxicologist / Pathologist
-
ex-Rheos, Agios, Millennium
Business Advisor
Keith Kendall, MBA
-
Experienced CEO with biotech, global strategy, business development, manufacturing, and operational experience
-
Deep financial and board exp.
Business Advisor
Jeremy Korst, MBA
-
Tech exec, board member and entrepreneur
-
Founding Partner at GBK Collective marketing consulting
-
Leadership roles at Microsoft, T-Mobile Wharton MBA and Board of Exec Ed.
Corporate Legal
Bruce Jenett, JD
-
Ex-head DLA Piper
-
45 years exp biotech startups
IP
Andy Kumamoto, JD
-
Ex-Cooley, McDermott, McCutchen
-
20 years exp biotech IP
Regulatory
Christopher Novashinski
-
Fractional Head of Regulatory
-
RareMoon cofounder and COO
Principal Scientist
Andrew Hou, PhD
-
Leading Rarefied's laboratory studies
-
~4 y industry experience
-
T cell immunologist
-
PhD in Chemical and Biomedical Engineering (UCLA)
Manish Butte, MD PhD
Our founder Dr. Butte has 20 years of experience as a practicing clinical immunologist and physician-scientist at world-leading academic institutions. He leads a large clinical and research enterprise, 200+ publications, NIH-funded for decades, founder of two prior startups.
World-class scientist, doctor, and leader
UCLA has no relationship with and does not endorse Rarefied Bio.
